Efficacy and safety outcomes of dulaglutide by baseline <scp>HbA1c</scp> : A post hoc analysis of the <scp>REWIND</scp> trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety outcomes of dulaglutide by baseline HbA1c : A post hoc analysis of the REWIND trial

Published:2022-05-30 Issue:9 Volume:24 Page:1753-1761
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Franek Edward¹,Gerstein Hertzel C.²^ORCID,Riddle Matthew C.³^ORCID,Nicolay Claudia⁴,Hickey Ana⁴,Botros Fady T.⁴^ORCID,Loo Li Shen⁴^ORCID

Affiliation:

1. Mossakowski Medical Research Centre Polish Academy of Sciences and Central Clinical Hospital MSWiA Warsaw Poland

2. Population Health Research Institute McMaster University and Hamilton Health Sciences Hamilton Ontario Canada

3. Department of Medicine Oregon Health & Science University Portland Oregon

4. Eli Lilly and Company Indianapolis Indiana

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14760

Reference27 articles.

1. Future glucose-lowering drugs for type 2 diabetes

2. Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project

3. Factors associated with good glycemic control among patients with type 2 diabetes mellitus

4. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

5. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: a narrative review;Diabetes & Metabolism;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3